<p><strong>碧生源控股有限公司</strong> (HKG:926) 的股票在过去一个月中继续保持其近期的势头，涨幅达到 39%。尽管最近有所上涨，但年初至今的股价回报率仅为 2.5%，并不算特别出色。</p>
<p>尽管其股价大幅上涨，但可以说碧生源控股的市销率（&#34;P/S&#34;）目前为 0.7 倍，相较于香港食品行业来看，似乎仍然处于&#34;中等水平&#34;，因为这与更广泛行业的 P/S 比率相匹配。不过，简单忽视 P/S 比率并不明智，因为投资者可能会忽略一个独特的机会或犯下昂贵的错误。</p>
<p>我们发现 21 只美国股票预计明年将支付超过 6% 的股息收益率。查看完整列表，免费获取。</p>
<p>查看我们对碧生源控股的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/113274181-ps-multiple-vs-industry-1-dark-2/1754518330763?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/113274181-ps-multiple-vs-industry-1-dark-2/1754518330763"/></p>
<p>SEHK:926 市销率与行业比较 2025 年 8 月 6 日</p>
<h3>碧生源控股最近的表现如何？</h3>
<p>碧生源控股的收入最近稳步上升，这令人欣慰。许多人可能预期其可观的收入表现会减弱，这使得 P/S 比率未能上升。看好碧生源控股的人希望这不是事实，以便他们能够以较低的估值买入该股票。</p>
<p>我们没有分析师的预测，但您可以通过查看我们关于碧生源控股的 <strong>免费</strong> 报告，了解近期趋势如何为公司未来铺路，包括收益、收入和现金流。</p>
<h2>碧生源控股是否有收入增长的预测？</h2>
<p>碧生源控股的 P/S 比率对于一家预计仅能实现适度增长的公司来说是典型的，重要的是，它的表现与行业保持一致。</p>
<p>回顾过去一年，公司收入增长了 7.6%。然而，这并未能扭转之前时期的糟糕表现，过去三年总收入缩水了 41%。因此，可以公平地说，最近的收入增长对公司来说并不理想。</p>
<p>与公司相比，行业其他部分预计在明年将增长 4.5%，这确实让公司的近期中期收入下降显得更加突出。</p>
<p>考虑到这一点，我们发现碧生源控股的 P/S 超过了其行业同行，这令人担忧。显然，许多投资者对该公司的看法远比近期的情况所表明的要乐观，并且目前不愿意抛售他们的股票。只有最勇敢的人才会认为这些价格是可持续的，因为近期收入趋势的持续可能最终会对股价造成压力。</p>
<h2>最终结论</h2>
<p>其股票大幅上涨，现在碧生源控股的 P/S 已回到行业中位数范围内。有人认为在某些行业中，市销率是一个较差的价值衡量标准，但它可以是一个强有力的商业情绪指标。</p>
<p>我们对碧生源控股的观察显示，其中期收入的下降并没有像我们预期的那样对 P/S 产生太大影响，因为行业预计将增长。尽管它与行业相匹配，但我们对当前的 P/S 比率感到不安，因为这种糟糕的收入表现不太可能长期支持更积极的情绪。如果近期中期收入趋势持续，将使股东的投资面临风险，并使潜在投资者面临支付不必要溢价的危险。</p>
<p>您应该始终考虑风险。举个例子，我们发现了 <strong>碧生源控股的 2 个警示信号</strong>，您应该注意。</p>
<p>如果您对盈利能力强的公司感兴趣，那么您会想查看这份 <strong>免费</strong> 的有趣公司名单，这些公司交易的市盈率较低（但已证明能够增长收益）。</p>

碧生源

<p>碧生源控股有限公司（HKG:926）的股价在过去一个月上涨了 39%，但年回报率仅为 2.5%。该公司的市销率（P/S）为 0.7 倍，与香港食品行业的平均水平相符。尽管最近收入有所增长，但公司在过去三年中经历了 41% 的收入下降。分析师预测适度增长，但考虑到行业预计 4.5% 的增长，当前市销率的可持续性仍然令人担忧。投资者应保持谨慎，因为持续的收入趋势可能会对股价产生负面影响</p>

<p><strong>Besunyen Holdings Company Limited</strong> (HKG:926) shares have continued their recent momentum with a 39% gain in the last month alone. Notwithstanding the latest gain, the annual share price return of 2.5% isn't as impressive.</p>
<div class="lb-trans"><p><strong>碧生源控股有限公司</strong> (HKG:926) 的股票在过去一个月中继续保持其近期的势头，涨幅达到 39%。尽管最近有所上涨，但年初至今的股价回报率仅为 2.5%，并不算特别出色。</p>
</div><p>Although its price has surged higher, it's still not a stretch to say that Besunyen Holdings' price-to-sales (or &#34;P/S&#34;) ratio of 0.7x right now seems quite &#34;middle-of-the-road&#34; compared to the Food industry in Hong Kong, seeing as it matches the P/S ratio of the wider industry. Although, it's not wise to simply ignore the P/S without explanation as investors may be disregarding a distinct opportunity or a costly mistake.</p>
<div class="lb-trans"><p>尽管其股价大幅上涨，但可以说碧生源控股的市销率（&#34;P/S&#34;）目前为 0.7 倍，相较于香港食品行业来看，似乎仍然处于&#34;中等水平&#34;，因为这与更广泛行业的 P/S 比率相匹配。不过，简单忽视 P/S 比率并不明智，因为投资者可能会忽略一个独特的机会或犯下昂贵的错误。</p>
</div><p>We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.</p>
<div class="lb-trans"><p>我们发现 21 只美国股票预计明年将支付超过 6% 的股息收益率。查看完整列表，免费获取。</p>
</div><p>View our latest analysis for Besunyen Holdings</p>
<div class="lb-trans"><p>查看我们对碧生源控股的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/113274181-ps-multiple-vs-industry-1-dark-2/1754518330763" alt="" original-src="https://images.simplywall.st/asset/chart/113274181-ps-multiple-vs-industry-1-dark-2/1754518330763"/></p>
<p>SEHK:926 Price to Sales Ratio vs Industry August 6th 2025</p>
<div class="lb-trans"><p>SEHK:926 市销率与行业比较 2025 年 8 月 6 日</p>
</div><h3>How Has Besunyen Holdings Performed Recently?</h3>
<div class="lb-trans"><h3>碧生源控股最近的表现如何？</h3>
</div><p>Revenue has risen firmly for Besunyen Holdings recently, which is pleasing to see. It might be that many expect the respectable revenue performance to wane, which has kept the P/S from rising. Those who are bullish on Besunyen Holdings will be hoping that this isn't the case, so that they can pick up the stock at a lower valuation.</p>
<div class="lb-trans"><p>碧生源控股的收入最近稳步上升，这令人欣慰。许多人可能预期其可观的收入表现会减弱，这使得 P/S 比率未能上升。看好碧生源控股的人希望这不是事实，以便他们能够以较低的估值买入该股票。</p>
</div><p>We don't have analyst forecasts, but you can see how recent trends are setting up the company for the future by checking out our <strong>free</strong> report on Besunyen Holdings' earnings, revenue and cash flow.</p>
<div class="lb-trans"><p>我们没有分析师的预测，但您可以通过查看我们关于碧生源控股的 <strong>免费</strong> 报告，了解近期趋势如何为公司未来铺路，包括收益、收入和现金流。</p>
</div><h2>Is There Some Revenue Growth Forecasted For Besunyen Holdings?</h2>
<div class="lb-trans"><h2>碧生源控股是否有收入增长的预测？</h2>
</div><p>Besunyen Holdings' P/S ratio would be typical for a company that's only expected to deliver moderate growth, and importantly, perform in line with the industry.</p>
<div class="lb-trans"><p>碧生源控股的 P/S 比率对于一家预计仅能实现适度增长的公司来说是典型的，重要的是，它的表现与行业保持一致。</p>
</div><p>Retrospectively, the last year delivered a decent 7.6% gain to the company's revenues. Ultimately though, it couldn't turn around the poor performance of the prior period, with revenue shrinking 41% in total over the last three years. Therefore, it's fair to say the revenue growth recently has been undesirable for the company.</p>
<div class="lb-trans"><p>回顾过去一年，公司收入增长了 7.6%。然而，这并未能扭转之前时期的糟糕表现，过去三年总收入缩水了 41%。因此，可以公平地说，最近的收入增长对公司来说并不理想。</p>
</div><p>In contrast to the company, the rest of the industry is expected to grow by 4.5% over the next year, which really puts the company's recent medium-term revenue decline into perspective.</p>
<div class="lb-trans"><p>与公司相比，行业其他部分预计在明年将增长 4.5%，这确实让公司的近期中期收入下降显得更加突出。</p>
</div><p>With this in mind, we find it worrying that Besunyen Holdings' P/S exceeds that of its industry peers. Apparently many investors in the company are way less bearish than recent times would indicate and aren't willing to let go of their stock right now. Only the boldest would assume these prices are sustainable as a continuation of recent revenue trends is likely to weigh on the share price eventually.</p>
<div class="lb-trans"><p>考虑到这一点，我们发现碧生源控股的 P/S 超过了其行业同行，这令人担忧。显然，许多投资者对该公司的看法远比近期的情况所表明的要乐观，并且目前不愿意抛售他们的股票。只有最勇敢的人才会认为这些价格是可持续的，因为近期收入趋势的持续可能最终会对股价造成压力。</p>
</div><h2>The Final Word</h2>
<div class="lb-trans"><h2>最终结论</h2>
</div><p>Its shares have lifted substantially and now Besunyen Holdings' P/S is back within range of the industry median. It's argued the price-to-sales ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.</p>
<div class="lb-trans"><p>其股票大幅上涨，现在碧生源控股的 P/S 已回到行业中位数范围内。有人认为在某些行业中，市销率是一个较差的价值衡量标准，但它可以是一个强有力的商业情绪指标。</p>
</div><p>Our look at Besunyen Holdings revealed its shrinking revenues over the medium-term haven't impacted the P/S as much as we anticipated, given the industry is set to grow. Even though it matches the industry, we're uncomfortable with the current P/S ratio, as this dismal revenue performance is unlikely to support a more positive sentiment for long. If recent medium-term revenue trends continue, it will place shareholders' investments at risk and potential investors in danger of paying an unnecessary premium.</p>
<div class="lb-trans"><p>我们对碧生源控股的观察显示，其中期收入的下降并没有像我们预期的那样对 P/S 产生太大影响，因为行业预计将增长。尽管它与行业相匹配，但我们对当前的 P/S 比率感到不安，因为这种糟糕的收入表现不太可能长期支持更积极的情绪。如果近期中期收入趋势持续，将使股东的投资面临风险，并使潜在投资者面临支付不必要溢价的危险。</p>
</div><p>You should always think about risks. Case in point, we've spotted <strong>2 warning signs for Besunyen Holdings</strong> you should be aware of.</p>
<div class="lb-trans"><p>您应该始终考虑风险。举个例子，我们发现了 <strong>碧生源控股的 2 个警示信号</strong>，您应该注意。</p>
</div><p>If strong companies turning a profit tickle your fancy, then you'll want to check out this <strong>free</strong> list of interesting companies that trade on a low P/E (but have proven they can grow earnings).</p>
<div class="lb-trans"><p>如果您对盈利能力强的公司感兴趣，那么您会想查看这份 <strong>免费</strong> 的有趣公司名单，这些公司交易的市盈率较低（但已证明能够增长收益）。</p>
</div>

碧生源控股有限公司（HKG:926）的股价虽然上涨了 39%，但其业务发展仍未跟上步伐